The discussion dives into the role of GLP1, a hormone that signals fullness and regulates food intake. When using GLP1 agonists like Ozempic, the body may reduce its natural production of this hormone, leading to potential challenges in weight management once the medication is stopped. The implications of relying on these drugs raise concerns about long-term effectiveness and the risk of regaining weight.
